Long-term survival after salvage pemetrexed for refractory primary T-cell lymphoma of the CNS
Primary T-cell CNS lymphoma is a rare and aggressive malignancy. High-dose methotrexate (MTX) based chemotherapy regimens are used as standard first-line treatment, followed by consolidative strategies to improve the duration of response. Although MTX-based therapy has been shown to be efficacious,...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Taylor & Francis Group
2023-09-01
|
| Colección: | CNS Oncology |
| Materias: | |
| Acceso en línea: | https://www.futuremedicine.com/doi/10.2217/cns-2022-0021 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
